EVERSEPT PARTNERS, LP Holdings

EVERSEPT PARTNERS, LP is an investment fund managing more than 978.36M US dollars. The largest holdings include Invesco QQQ Trust, Biohaven Ltd. and GSK. In Q3 2022 the fund bought assets of total value of 235.72M US dollars and sold assets of total value of 469.7M US dollars.

$978.36M

portfolio value

-7.87%

quarter

-32.62%

1 year

-17.32%

3 years

EVERSEPT PARTNERS, LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2018	92570000	33927000
Q2 2018	43539000	18158000
Q3 2018	67679000	47920000
Q4 2018	31121000	45267000
Q1 2019	168726000	11903000
Q2 2019	80730000	59086000
Q3 2019	87168000	120984000
Q4 2019	217588000	32654000
Q1 2020	109635000	185872000
Q2 2020	321094000	102851000
Q3 2020	89459000	262783000
Q4 2020	452068000	47532000
Q1 2021	557749000	134632000
Q2 2021	394172000	394141000
Q3 2021	419738000	333701000
Q4 2021	312816000	252495000
Q1 2022	215602000	346757000
Q2 2022	308033000	297352000
Q3 2022	235717000	469703000

EVERSEPT PARTNERS, LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Invesco QQQ Trust Portfolio share: 11.27% Portfolio value: 110.29M Avg. open price: $292.58 Current price: $287.73 P/L: -1.66% Bought +189.52% shares Q3 2022	share	11.27%	110.29M	$292.58	$287.73	-1.66%	Bought +189.52% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 9.84% Portfolio value: 96.31M Avg. open price: $85.6 Current price: $16.32 P/L: -80.94% Bought +0.69% shares Q3 2022	share	9.84%	96.31M	$85.6	$16.32	-80.94%	Bought +0.69% shares Q3 2022
Drug Manufacturers—General GSK plc Portfolio share: 8.92% Portfolio value: 87.26M Avg. open price: $38.06 Current price: $35.16 P/L: -7.61% N/A Q3 2022	share	8.92%	87.26M	$38.06	$35.16	-7.61%	N/A Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 8.03% Portfolio value: 78.57M Avg. open price: $91.45 Current price: $98.48 P/L: +7.69% Bought +42.72% shares Q3 2022	share	8.03%	78.57M	$91.45	$98.48	+7.69%	Bought +42.72% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 6.39% Portfolio value: 62.47M Avg. open price: $43.07 Current price: $40.39 P/L: -6.22% Bought +199.71% shares Q3 2022	share	6.39%	62.47M	$43.07	$40.39	-6.22%	Bought +199.71% shares Q3 2022
Biotechnology United Therapeutics Corporation Portfolio share: 5.46% Portfolio value: 53.43M Avg. open price: $112.53 Current price: $273.72 P/L: +143.24% Sold -17.89% shares Q3 2022	share	5.46%	53.43M	$112.53	$273.72	+143.24%	Sold -17.89% shares Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 4.30% Portfolio value: 42.02M Avg. open price: $177.94 Current price: $267.97 P/L: +50.60% Sold -9.53% shares Q3 2022	share	4.30%	42.02M	$177.94	$267.97	+50.60%	Sold -9.53% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 3.87% Portfolio value: 37.86M Avg. open price: $42.18 Current price: $44.93 P/L: +6.52% Bought +13.26% shares Q3 2022	share	3.87%	37.86M	$42.18	$44.93	+6.52%	Bought +13.26% shares Q3 2022
Drug Manufacturers—Specialty & Generic Teva Pharmaceutical Industries Limited Portfolio share: 3.35% Portfolio value: 32.78M Avg. open price: $8.8 Current price: $8.62 P/L: -2.04% Sold -9.93% shares Q3 2022	share	3.35%	32.78M	$8.8	$8.62	-2.04%	Sold -9.93% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 2.98% Portfolio value: 29.11M Avg. open price: $19.24 Current price: $25.44 P/L: +32.22% Bought +21.83% shares Q3 2022	share	2.98%	29.11M	$19.24	$25.44	+32.22%	Bought +21.83% shares Q3 2022
Medical Instruments & Supplies Envista Holdings Corporation Portfolio share: 2.12% Portfolio value: 20.76M Avg. open price: $38.01 Current price: $33.51 P/L: -11.84% Sold -3.96% shares Q3 2022	share	2.12%	20.76M	$38.01	$33.51	-11.84%	Sold -3.96% shares Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 2.09% Portfolio value: 20.41M Avg. open price: $223.25 Current price: $213.86 P/L: -4.21% Bought +203.41% shares Q3 2022	share	2.09%	20.41M	$223.25	$213.86	-4.21%	Bought +203.41% shares Q3 2022
Medical Care Facilities Community Health Systems, Inc. Portfolio share: 1.94% Portfolio value: 19.00M Avg. open price: $11.21 Current price: $3.31 P/L: -70.46% Bought +9.69% shares Q3 2022	share	1.94%	19.00M	$11.21	$3.31	-70.46%	Bought +9.69% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 1.80% Portfolio value: 17.60M Avg. open price: $31.41 Current price: $36.66 P/L: +16.71% Bought +13.39% shares Q3 2022	share	1.80%	17.60M	$31.41	$36.66	+16.71%	Bought +13.39% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 1.64% Portfolio value: 16.05M Avg. open price: $229.93 Current price: $292.75 P/L: +27.32% Sold -40.69% shares Q3 2022	share	1.64%	16.05M	$229.93	$292.75	+27.32%	Sold -40.69% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 1.53% Portfolio value: 15.00M Avg. open price: $491.22 Current price: $522.34 P/L: +6.34% Sold -22.78% shares Q3 2022	share	1.53%	15.00M	$491.22	$522.34	+6.34%	Sold -22.78% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 1.52% Portfolio value: 14.88M Avg. open price: $69.25 Current price: $86.35 P/L: +24.70% Sold -18.12% shares Q3 2022	share	1.52%	14.88M	$69.25	$86.35	+24.70%	Sold -18.12% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 1.49% Portfolio value: 14.55M Avg. open price: $66.03 Current price: $56.01 P/L: -15.17% Bought +14.91% shares Q3 2022	share	1.49%	14.55M	$66.03	$56.01	-15.17%	Bought +14.91% shares Q3 2022
Biotechnology AMARIN CORP PLC Portfolio share: 1.33% Portfolio value: 13.03M Avg. open price: $7.23 Current price: $1.18 P/L: -83.75% Sold -9.95% shares Q3 2022	share	1.33%	13.03M	$7.23	$1.18	-83.75%	Sold -9.95% shares Q3 2022
Medical Devices Abiomed, Inc. Portfolio share: 1.33% Portfolio value: 13.01M Avg. open price: $379.89 Current price: $378.26 P/L: -0.43% Sold -23.56% shares Q3 2022	share	1.33%	13.01M	$379.89	$378.26	-0.43%	Sold -23.56% shares Q3 2022
Biotechnology Seres Therapeutics, Inc. Portfolio share: 1.27% Portfolio value: 12.42M Avg. open price: N/A Current price: $6.53 P/L: N/A N/A Q3 2022	share	1.27%	12.42M	N/A	$6.53	N/A	N/A Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 1.22% Portfolio value: 11.94M Avg. open price: $449.89 Current price: $547.42 P/L: +21.68% Bought +119.98% shares Q3 2022	share	1.22%	11.94M	$449.89	$547.42	+21.68%	Bought +119.98% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 1.00% Portfolio value: 9.81M Avg. open price: $17.66 Current price: $26.84 P/L: +52.01% Bought +7.36% shares Q3 2022	share	1.00%	9.81M	$17.66	$26.84	+52.01%	Bought +7.36% shares Q3 2022
Drug Manufacturers—Specialty & Generic Amneal Pharmaceuticals, Inc. Portfolio share: 0.97% Portfolio value: 9.47M Avg. open price: $4.96 Current price: $2.37 P/L: -52.20% Sold -14.62% shares Q3 2022	share	0.97%	9.47M	$4.96	$2.37	-52.20%	Sold -14.62% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.96% Portfolio value: 9.37M Avg. open price: $29.91 Current price: $38.83 P/L: +29.82% Sold -44.28% shares Q3 2022	share	0.96%	9.37M	$29.91	$38.83	+29.82%	Sold -44.28% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.94% Portfolio value: 9.23M Avg. open price: $89.84 Current price: $51.95 P/L: -42.17% Sold -57.80% shares Q3 2022	share	0.94%	9.23M	$89.84	$51.95	-42.17%	Sold -57.80% shares Q3 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 0.91% Portfolio value: 8.92M Avg. open price: $37.22 Current price: $38.98 P/L: +4.74% Bought +133.84% shares Q3 2022	share	0.91%	8.92M	$37.22	$38.98	+4.74%	Bought +133.84% shares Q3 2022
GSK PLC Portfolio share: 0.90% Portfolio value: 8.83M Avg. open price: N/A Current price: N/A P/L: N/A Bought +34.76% shares Q3 2022	share	0.90%	8.83M	N/A	N/A	N/A	Bought +34.76% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.81% Portfolio value: 7.93M Avg. open price: N/A Current price: $82.88 P/L: N/A Sold -71.92% shares Q3 2022	share	0.81%	7.93M	N/A	$82.88	N/A	Sold -71.92% shares Q3 2022
Biotechnology Liquidia Corporation Portfolio share: 0.78% Portfolio value: 7.62M Avg. open price: $4.63 Current price: $5.18 P/L: +11.97% Sold -33.26% shares Q3 2022	share	0.78%	7.62M	$4.63	$5.18	+11.97%	Sold -33.26% shares Q3 2022
Drug Manufacturers—Specialty & Generic Taro Pharmaceutical Industries Ltd. Portfolio share: 0.68% Portfolio value: 6.69M Avg. open price: $69.69 Current price: $30.33 P/L: -56.48% Bought +1.36% shares Q3 2022	share	0.68%	6.69M	$69.69	$30.33	-56.48%	Bought +1.36% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.68% Portfolio value: 6.62M Avg. open price: $229.93 Current price: $292.75 P/L: +27.32% N/A Q3 2022	share	0.68%	6.62M	$229.93	$292.75	+27.32%	N/A Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 0.67% Portfolio value: 6.57M Avg. open price: $10.34 Current price: $9.29 P/L: -10.18% Bought +17.11% shares Q3 2022	share	0.67%	6.57M	$10.34	$9.29	-10.18%	Bought +17.11% shares Q3 2022
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 0.63% Portfolio value: 6.14M Avg. open price: N/A Current price: $17 P/L: N/A N/A Q3 2022	share	0.63%	6.14M	N/A	$17	N/A	N/A Q3 2022
Biotechnology Merus N.V. Portfolio share: 0.57% Portfolio value: 5.54M Avg. open price: $27.7 Current price: $14.2 P/L: -48.73% Sold -3.87% shares Q3 2022	share	0.57%	5.54M	$27.7	$14.2	-48.73%	Sold -3.87% shares Q3 2022
Biotechnology Maravai LifeSciences Holdings, Inc. Portfolio share: 0.42% Portfolio value: 4.08M Avg. open price: $41.73 Current price: $13.34 P/L: -68.03% Sold -62.39% shares Q3 2022	share	0.42%	4.08M	$41.73	$13.34	-68.03%	Sold -62.39% shares Q3 2022
Biotechnology Affimed N.V. Portfolio share: 0.40% Portfolio value: 3.88M Avg. open price: $2.96 Current price: $2.12 P/L: -28.45% Bought +66.97% shares Q3 2022	share	0.40%	3.88M	$2.96	$2.12	-28.45%	Bought +66.97% shares Q3 2022
Drug Manufacturers—Specialty & Generic Aerie Pharmaceuticals, Inc. Portfolio share: 0.40% Portfolio value: 3.87M Avg. open price: $60.63 Current price: $15.25 P/L: -74.85% N/A Q3 2022	share	0.40%	3.87M	$60.63	$15.25	-74.85%	N/A Q3 2022
SPDR SER TR Portfolio share: 0.38% Portfolio value: 3.71M Avg. open price: N/A Current price: N/A P/L: N/A Sold -65.36% shares Q3 2022	share	0.38%	3.71M	N/A	N/A	N/A	Sold -65.36% shares Q3 2022
Biotechnology Puma Biotechnology, Inc. Portfolio share: 0.36% Portfolio value: 3.56M Avg. open price: $6.43 Current price: $4.31 P/L: -33.02% Bought +4.92% shares Q3 2022	share	0.36%	3.56M	$6.43	$4.31	-33.02%	Bought +4.92% shares Q3 2022
Biotechnology Vera Therapeutics, Inc. Portfolio share: 0.34% Portfolio value: 3.32M Avg. open price: N/A Current price: $16.19 P/L: N/A N/A Q3 2022	share	0.34%	3.32M	N/A	$16.19	N/A	N/A Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.32% Portfolio value: 3.17M Avg. open price: $31.43 Current price: $20.4 P/L: -35.08% Sold -80.52% shares Q3 2022	share	0.32%	3.17M	$31.43	$20.4	-35.08%	Sold -80.52% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.32% Portfolio value: 3.17M Avg. open price: N/A Current price: $6.72 P/L: N/A N/A Q3 2022	share	0.32%	3.17M	N/A	$6.72	N/A	N/A Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 0.32% Portfolio value: 3.16M Avg. open price: N/A Current price: $110.01 P/L: N/A N/A Q2 2021	share	0.32%	3.16M	N/A	$110.01	N/A	N/A Q2 2021
Diagnostics & Research Agilent Technologies, Inc. Portfolio share: 0.27% Portfolio value: 2.61M Avg. open price: $126.61 Current price: $150.01 P/L: +18.49% Bought +6.20% shares Q3 2022	share	0.27%	2.61M	$126.61	$150.01	+18.49%	Bought +6.20% shares Q3 2022
Medical Devices 908 Devices Inc. Portfolio share: 0.22% Portfolio value: 2.15M Avg. open price: $19.01 Current price: $9.4 P/L: -50.55% Sold -72.20% shares Q3 2022	share	0.22%	2.15M	$19.01	$9.4	-50.55%	Sold -72.20% shares Q3 2022
Diagnostics & Research ICON Public Limited Company Portfolio share: 0.19% Portfolio value: 1.87M Avg. open price: $216.7 Current price: $204.76 P/L: -5.51% Bought +82.78% shares Q3 2022	share	0.19%	1.87M	$216.7	$204.76	-5.51%	Bought +82.78% shares Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 0.17% Portfolio value: 1.71M Avg. open price: $290.45 Current price: $269.72 P/L: -7.14% Bought +6.22% shares Q3 2022	share	0.17%	1.71M	$290.45	$269.72	-7.14%	Bought +6.22% shares Q3 2022
Biotechnology XOMA Corporation Portfolio share: 0.16% Portfolio value: 1.58M Avg. open price: N/A Current price: $19.65 P/L: N/A N/A Q3 2022	share	0.16%	1.58M	N/A	$19.65	N/A	N/A Q3 2022
Diagnostics & Research IQVIA Holdings Inc. Portfolio share: 0.15% Portfolio value: 1.50M Avg. open price: $262.77 Current price: $211.93 P/L: -19.35% Bought +37.73% shares Q3 2022	share	0.15%	1.50M	$262.77	$211.93	-19.35%	Bought +37.73% shares Q3 2022
Diagnostics & Research Laboratory Corporation of America Holdings Portfolio share: 0.15% Portfolio value: 1.48M Avg. open price: $234.36 Current price: $236.39 P/L: +0.87% Bought +35.10% shares Q3 2022	share	0.15%	1.48M	$234.36	$236.39	+0.87%	Bought +35.10% shares Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 0.15% Portfolio value: 1.45M Avg. open price: $34.31 Current price: $22.35 P/L: -34.86% Sold -93.35% shares Q3 2022	share	0.15%	1.45M	$34.31	$22.35	-34.86%	Sold -93.35% shares Q3 2022
Biotechnology Aadi Bioscience, Inc. Portfolio share: 0.15% Portfolio value: 1.44M Avg. open price: $12.32 Current price: $13.42 P/L: +8.89% Bought +1.09% shares Q3 2022	share	0.15%	1.44M	$12.32	$13.42	+8.89%	Bought +1.09% shares Q3 2022
Diagnostics & Research PerkinElmer, Inc. Portfolio share: 0.13% Portfolio value: 1.31M Avg. open price: $156.48 Current price: $136.94 P/L: -12.49% Bought +6.19% shares Q3 2022	share	0.13%	1.31M	$156.48	$136.94	-12.49%	Bought +6.19% shares Q3 2022
Biotechnology argenx SE Portfolio share: 0.13% Portfolio value: 1.23M Avg. open price: $213.34 Current price: $393.21 P/L: +84.31% Sold -92.87% shares Q3 2022	share	0.13%	1.23M	$213.34	$393.21	+84.31%	Sold -92.87% shares Q3 2022
Biotechnology Milestone Pharmaceuticals Inc. Portfolio share: 0.12% Portfolio value: 1.16M Avg. open price: $5.71 Current price: $4.75 P/L: -16.81% Sold -13.82% shares Q3 2022	share	0.12%	1.16M	$5.71	$4.75	-16.81%	Sold -13.82% shares Q3 2022
Drug Manufacturers—Specialty & Generic Teva Pharmaceutical Industries Limited Portfolio share: 0.10% Portfolio value: 953K Avg. open price: N/A Current price: $8.7 P/L: N/A N/A Q3 2022	share	0.10%	953K	N/A	$8.7	N/A	N/A Q3 2022
Medical Care Facilities AMN Healthcare Services, Inc. Portfolio share: 0.09% Portfolio value: 876K Avg. open price: N/A Current price: $120.24 P/L: N/A N/A Q3 2022	share	0.09%	876K	N/A	$120.24	N/A	N/A Q3 2022
Medical Instruments & Supplies Repligen Corporation Portfolio share: 0.07% Portfolio value: 681K Avg. open price: $255.59 Current price: $178.61 P/L: -30.12% Sold -36.04% shares Q3 2022	share	0.07%	681K	$255.59	$178.61	-30.12%	Sold -36.04% shares Q3 2022
BIOGEN INC Portfolio share: 0.06% Portfolio value: 582K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.06%	582K	N/A	N/A	N/A	N/A Q3 2022
Medical Devices Heska Corporation Portfolio share: 0.05% Portfolio value: 506K Avg. open price: $60.48 Current price: $66.42 P/L: +9.82% Sold -10.67% shares Q3 2022	share	0.05%	506K	$60.48	$66.42	+9.82%	Sold -10.67% shares Q3 2022
Biotechnology AC Immune SA Portfolio share: 0.04% Portfolio value: 394K Avg. open price: N/A Current price: $2.42 P/L: N/A Sold -18.77% shares Q1 2022	share	0.04%	394K	N/A	$2.42	N/A	Sold -18.77% shares Q1 2022
Biotechnology Cabaletta Bio, Inc. Portfolio share: 0.04% Portfolio value: 364K Avg. open price: N/A Current price: $4.97 P/L: N/A N/A Q3 2022	share	0.04%	364K	N/A	$4.97	N/A	N/A Q3 2022
Medical Care Facilities Sonida Senior Living, Inc. Portfolio share: 0.02% Portfolio value: 191K Avg. open price: N/A Current price: $16.26 P/L: N/A Sold -22.47% shares Q3 2022	share	0.02%	191K	N/A	$16.26	N/A	Sold -22.47% shares Q3 2022
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 0.02% Portfolio value: 190K Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	0.02%	190K	N/A	$22	N/A	N/A Q3 2022
Biotechnology Eledon Pharmaceuticals, Inc. Portfolio share: 0.02% Portfolio value: 187K Avg. open price: $2.44 Current price: $2.43 P/L: -0.41% Bought +14.69% shares Q3 2022	share	0.02%	187K	$2.44	$2.43	-0.41%	Bought +14.69% shares Q3 2022
Biotechnology Maravai LifeSciences Holdings, Inc. Portfolio share: 0.02% Portfolio value: 170K Avg. open price: $41.73 Current price: $13.34 P/L: -68.03% N/A Q3 2022	share	0.02%	170K	$41.73	$13.34	-68.03%	N/A Q3 2022
Biotechnology GlycoMimetics, Inc. Portfolio share: 0.01% Portfolio value: 55K Avg. open price: $1.46 Current price: $2.25 P/L: +54.11% Bought +0.58% shares Q1 2022	share	0.01%	55K	$1.46	$2.25	+54.11%	Bought +0.58% shares Q1 2022
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 0.00% Portfolio value: 46K Avg. open price: N/A Current price: $1.4 P/L: N/A N/A Q2 2022	share	0.00%	46K	N/A	$1.4	N/A	N/A Q2 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $31.41 Current price: $36.66 P/L: +16.71% Sold -100.00% shares Q3 2022	share	0.00%	0	$31.41	$36.66	+16.71%	Sold -100.00% shares Q3 2022
ASTRAZENECA PLC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $82.68 Current price: $20.26 P/L: -75.50% Sold -100.00% shares Q3 2022	share	0.00%	0	$82.68	$20.26	-75.50%	Sold -100.00% shares Q3 2022
ARK Innovation ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $110.85 Current price: $36.07 P/L: -67.46% Sold -100.00% shares Q3 2022	share	0.00%	0	$110.85	$36.07	-67.46%	Sold -100.00% shares Q3 2022
Diagnostics & Research Qiagen N.V. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $50.08 Current price: $49.18 P/L: -1.79% Sold -100.00% shares Q3 2022	share	0.00%	0	$50.08	$49.18	-1.79%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies Masimo Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $142.55 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$142.55	N/A	Sold -100.00% shares Q3 2022
iShares $ Treasury Bond 1-3yr UCITS ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.22 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.22	N/A	Sold -100.00% shares Q3 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $12.37 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$12.37	N/A	Sold -100.00% shares Q3 2022
Health Information Services HealthEquity, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $64.76 Current price: $67.73 P/L: +4.59% Sold -100.00% shares Q3 2022	share	0.00%	0	$64.76	$67.73	+4.59%	Sold -100.00% shares Q3 2022
Biotechnology AnaptysBio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $26.18 Current price: $28.65 P/L: +9.45% Sold -100.00% shares Q3 2022	share	0.00%	0	$26.18	$28.65	+9.45%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Radius Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $22.43 Current price: $10.08 P/L: -55.06% Sold -100.00% shares Q3 2022	share	0.00%	0	$22.43	$10.08	-55.06%	Sold -100.00% shares Q3 2022
Health Information Services R1 RCM Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $13.17 Current price: $10.11 P/L: -23.25% Sold -100.00% shares Q3 2022	share	0.00%	0	$13.17	$10.11	-23.25%	Sold -100.00% shares Q3 2022
SPDR S&P 500 ETF Trust Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $295.89 Current price: $400.01 P/L: +35.19% Sold -100.00% shares Q3 2022	share	0.00%	0	$295.89	$400.01	+35.19%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General GSK plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $38.06 Current price: $35.16 P/L: -7.61% Sold -100.00% shares Q3 2022	share	0.00%	0	$38.06	$35.16	-7.61%	Sold -100.00% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $161.03 Current price: $226.4 P/L: +40.59% Sold -100.00% shares Q3 2022	share	0.00%	0	$161.03	$226.4	+40.59%	Sold -100.00% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $243.11 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$243.11	N/A	Sold -100.00% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $427.53 Current price: $116.56 P/L: -72.74% Sold -100.00% shares Q3 2022	share	0.00%	0	$427.53	$116.56	-72.74%	Sold -100.00% shares Q3 2022
Medical Devices Tandem Diabetes Care, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $42.44 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$42.44	N/A	Sold -100.00% shares Q3 2022
Medical Care Facilities Community Health Systems, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $11.21 Current price: $3.31 P/L: -70.46% Sold -100.00% shares Q3 2022	share	0.00%	0	$11.21	$3.31	-70.46%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $53.28 Current price: $68.42 P/L: +28.42% Sold -100.00% shares Q3 2022	share	0.00%	0	$53.28	$68.42	+28.42%	Sold -100.00% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $31.41 Current price: $36.66 P/L: +16.71% Sold -100.00% shares Q3 2022	share	0.00%	0	$31.41	$36.66	+16.71%	Sold -100.00% shares Q3 2022

Showing TOP 90 EVERSEPT PARTNERS, LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of EVERSEPT PARTNERS, LP?

The biggest position of the EVERSEPT PARTNERS, LP is Invesco QQQ Trust (QQQ) with 11.27% portfolio share worth of 110.29M US dollars.

Top 5 EVERSEPT PARTNERS, LP's holdings represent 44.45% of the portfolio:

Invesco QQQ Trust (QQQ) – 11.27%
Biohaven Ltd. (BHVN) – 9.84%
GSK plc (GSK) – 8.92%
Horizon Therapeutics Public Limited Company (HZNP) – 8.03%
Natera, Inc. (NTRA) – 6.39%

Who is the portfolio manager of EVERSEPT PARTNERS, LP?

The portfolio manager of the EVERSEPT PARTNERS, LP is .

What is the total asset value of the EVERSEPT PARTNERS, LP portfolio?

EVERSEPT PARTNERS, LP total asset value (portfolio value) is 978.36M US dollars.

Who is ?

is the portfolio manager of the EVERSEPT PARTNERS, LP.

What is (EVERSEPT PARTNERS, LP) fund performance?

EVERSEPT PARTNERS, LP's quarterly performance is -7.87%, annualy -32.62%. In the past 3 years, the value of 's portfolio has decreased by -17%.

What is the EVERSEPT PARTNERS, LP CIK?

EVERSEPT PARTNERS, LP's Central Index Key is 0001697013 .